Suppr超能文献

累及甲状腺的乳腺样分泌性癌(MASC):首例3例报告

Mammary Analog Secretory Carcinoma (MASC) Involving the Thyroid Gland: A Report of the First 3 Cases.

作者信息

Dettloff Jennifer, Seethala Raja R, Stevens Todd M, Brandwein-Gensler Margaret, Centeno Barbara A, Otto Kristen, Bridge Julia A, Bishop Justin A, Leon Marino E

机构信息

Department of Pathology and Cell Biology, Morsani College of Medicine, University of South Florida, Tampa, FL, 33612, USA.

Department of Pathology and Laboratory Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, 15213, USA.

出版信息

Head Neck Pathol. 2017 Jun;11(2):124-130. doi: 10.1007/s12105-016-0741-6. Epub 2016 Jul 11.

Abstract

Salivary gland-type tumors have been rarely described in the thyroid gland. Mammary Analog Secretory Carcinoma (MASC) is a recently defined type of salivary gland carcinoma characterized by a t(12;15)(p13;q25) resulting in an ETV6-NTRK3 fusion gene. We report 3 cases of MASC involving the thyroid gland without clinical evidence of a salivary gland or breast primary; the clinico-pathologic characteristics are reviewed. Assessment for rearrangement of the ETV6 (12p13) locus was conducted by fluorescence in situ hybridization (FISH) on representative FFPE sections using an ETV6 break apart probe (Abbott Molecular, Des Plaines, IL, USA). The patients were two females (52 and 55 years-old) and 1 male (74 years-old). The tumors were poorly circumscribed solid white tan nodules involving the thyroid. Histologically, they were invasive and showed solid, microcystic, cribriform, and tubular growth patterns composed of variably bland polygonal eosinophilic cells with vesicular nuclear chromatin and conspicuous nucleoli. All three cases showed metastasis to lymph nodes; one case showed lateral neck involvement. The tumor cells were positive for S100 and mammaglobin. GATA-3 and PAX-8 were positive in 2 cases, one of which only focally so. All three cases were negative for TTF-1 and thyroglobulin. Rearrangement of the ETV6 locus was confirmed in all cases and a diagnosis of MASC rendered for each case. A site of origin distinct from the thyroid gland was not identified, with a median follow up of 24 months. MASC may rarely involve the thyroid gland. The origin of these lesions is unknown; while an origin from ectopic salivary gland-type cells is entertained, a metastatic origin from an occult primary cannot be definitively excluded at this time. Given the histologic (follicular-like microcystic pattern with colloid-like secretions and papillary pattern), immunophenotypic (PAX-8), and even molecular overlap, MASC can be mistaken for papillary thyroid carcinoma and should be considered in the differential diagnosis of a thyroid mass.

摘要

涎腺型肿瘤在甲状腺中鲜有报道。乳腺类似物分泌癌(MASC)是一种最近定义的涎腺癌类型,其特征为t(12;15)(p13;q25),导致ETV6-NTRK3融合基因。我们报告3例累及甲状腺的MASC病例,临床上无涎腺或乳腺原发灶的证据;并对其临床病理特征进行了回顾。使用ETV6分离探针(美国伊利诺伊州德斯普兰斯市雅培分子公司),通过荧光原位杂交(FISH)对代表性的福尔马林固定石蜡包埋(FFPE)切片进行ETV6(12p13)基因座重排评估。患者为2名女性(分别为52岁和55岁)和1名男性(74岁)。肿瘤为边界不清的实性灰白色结节,累及甲状腺。组织学上,肿瘤具有侵袭性,呈实性、微囊状、筛状和管状生长模式,由形态不一的温和多边形嗜酸性细胞组成,细胞核染色质呈泡状,核仁明显。所有3例均有淋巴结转移;1例累及侧颈部。肿瘤细胞S100和乳珠蛋白呈阳性。GATA-3和PAX-8在2例中呈阳性,其中1例仅局灶阳性。所有3例TTF-1和甲状腺球蛋白均为阴性。所有病例均证实有ETV6基因座重排,每例均诊断为MASC。随访中位时间为24个月,未发现甲状腺以外的原发部位。MASC可能很少累及甲状腺。这些病变的起源尚不清楚;虽然考虑起源于异位涎腺型细胞,但目前不能明确排除隐匿原发灶转移的可能性。鉴于其组织学(具有胶样分泌物的滤泡样微囊状模式和乳头状模式)、免疫表型(PAX-8)甚至分子特征的重叠,MASC可能被误诊为甲状腺乳头状癌,在甲状腺肿块的鉴别诊断中应予以考虑。

相似文献

1
Mammary Analog Secretory Carcinoma (MASC) Involving the Thyroid Gland: A Report of the First 3 Cases.
Head Neck Pathol. 2017 Jun;11(2):124-130. doi: 10.1007/s12105-016-0741-6. Epub 2016 Jul 11.
2
Mammary analog secretory carcinoma of the thyroid gland: A primary thyroid adenocarcinoma harboring ETV6-NTRK3 fusion.
Mod Pathol. 2016 Sep;29(9):985-95. doi: 10.1038/modpathol.2016.115. Epub 2016 Jun 10.
3
Mammary Analogue Secretory Carcinoma of the Thyroid Mimicking Locally Advanced Papillary Thyroid Carcinoma: A Rare Case Report.
Int J Surg Pathol. 2018 Aug;26(5):459-463. doi: 10.1177/1066896917747076. Epub 2017 Dec 12.
5
Clinicopathologic and molecular characterization of mammary analogue secretory carcinoma of salivary gland origin.
Pathol Res Pract. 2017 Sep;213(9):1112-1118. doi: 10.1016/j.prp.2017.07.017. Epub 2017 Jul 23.
6
[Clinicopathologic features of mammary analogue secretory carcinoma of salivary glands].
Zhonghua Bing Li Xue Za Zhi. 2017 Jan 8;46(1):34-37. doi: 10.3760/cma.j.issn.0529-5807.2017.01.008.
7
Mammary analog secretory carcinoma of thyroid: A case report.
Diagn Cytopathol. 2017 Jan;45(1):45-50. doi: 10.1002/dc.23608. Epub 2016 Sep 15.
8
Mammary analog secretory carcinoma of the thyroid gland: A rare cancer harboring TRK fusion.
Oral Oncol. 2021 Apr;115:105092. doi: 10.1016/j.oraloncology.2020.105092. Epub 2020 Nov 12.
9
Mammary analogue secretory carcinoma of salivary glands: a clinicopathologic study of 11 cases.
Ann Diagn Pathol. 2016 Jun;22:49-53. doi: 10.1016/j.anndiagpath.2016.04.003. Epub 2016 Apr 11.

引用本文的文献

1
Primary secretory carcinoma of thyroid with unusual features mimicking metastasis?
Diagn Pathol. 2025 Jul 30;20(1):90. doi: 10.1186/s13000-025-01693-4.
2
Secretory Carcinoma of the Thyroid: A Case Report and Update of Literature.
Head Neck Pathol. 2024 Sep 22;18(1):84. doi: 10.1007/s12105-024-01693-8.
3
Breast metastasis from thyroid follicular carcinoma in a 90-year-old patient 12 years after thyroidectomy and radiotherapy.
Radiol Case Rep. 2022 Aug 12;17(10):3911-3914. doi: 10.1016/j.radcr.2022.07.047. eCollection 2022 Oct.
4
Secretory carcinoma of the salivary gland, a rare entity: An international multi-institutional study.
Cancer Cytopathol. 2022 Sep;130(9):684-694. doi: 10.1002/cncy.22574. Epub 2022 Apr 6.
5
A Poorly Differentiated Non-keratinizing Sinonasal Squamous Cell Carcinoma with a Novel ETV6-TNFRSF8 Fusion Gene.
Head Neck Pathol. 2021 Dec;15(4):1284-1288. doi: 10.1007/s12105-020-01249-6. Epub 2021 Jan 4.
6
Pitfalls in Challenging Thyroid Tumors: Emphasis on Differential Diagnosis and Ancillary Biomarkers.
Endocr Pathol. 2020 Sep;31(3):197-217. doi: 10.1007/s12022-020-09638-x. Epub 2020 Jul 6.
7
Salivary-Like Tumors of the Thyroid: A Comprehensive Review of Three Rare Carcinomas.
Head Neck Pathol. 2021 Mar;15(1):212-224. doi: 10.1007/s12105-020-01193-5. Epub 2020 Jun 19.
8
Secretory carcinoma of the breast: clinicopathologic profile of 14 cases emphasising distant metastatic potential.
Histopathology. 2019 Aug;75(2):213-224. doi: 10.1111/his.13879. Epub 2019 Jul 10.
10
An Unusual Salivary Gland Tumor Mimicking Papillary Thyroid Carcinoma: Mammary Analog Secretory Carcinoma.
Front Endocrinol (Lausanne). 2018 Sep 25;9:555. doi: 10.3389/fendo.2018.00555. eCollection 2018.

本文引用的文献

2
Mammary analog secretory carcinoma, low-grade salivary duct carcinoma, and mimickers: a comparative study.
Mod Pathol. 2015 Aug;28(8):1084-100. doi: 10.1038/modpathol.2015.64. Epub 2015 Jun 19.
3
Integrated genomic characterization of papillary thyroid carcinoma.
Cell. 2014 Oct 23;159(3):676-90. doi: 10.1016/j.cell.2014.09.050.
4
ETV6-NTRK3 is a common chromosomal rearrangement in radiation-associated thyroid cancer.
Cancer. 2014 Mar 15;120(6):799-807. doi: 10.1002/cncr.28484. Epub 2013 Dec 10.
6
Most nonparotid "acinic cell carcinomas" represent mammary analog secretory carcinomas.
Am J Surg Pathol. 2013 Jul;37(7):1053-7. doi: 10.1097/PAS.0b013e3182841554.
7
Mammary analogue secretory carcinoma mimicking salivary adenoma.
Head Neck Pathol. 2013 Dec;7(4):316-9. doi: 10.1007/s12105-013-0443-2. Epub 2013 Apr 26.
8
The cytological features of mammary analogue secretory carcinoma: a series of 6 molecularly confirmed cases.
Cancer Cytopathol. 2013 May;121(5):234-41. doi: 10.1002/cncy.21249. Epub 2012 Dec 5.
9
Cytopathologic features of mammary analogue secretory carcinoma.
Cancer Cytopathol. 2013 May;121(5):228-33. doi: 10.1002/cncy.21245. Epub 2012 Oct 5.
10
Mammary analog secretory carcinoma of salivary glands: a report of 2 cases in the lips.
Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Nov;114(5):630-5. doi: 10.1016/j.oooo.2012.07.480. Epub 2012 Sep 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验